✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Ipsen SA

Common Name
Ipsen
Country
France
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,535
Ticker
IPN
Exchange
Euronext Paris
Description
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology...

Ipsen's Financial Statements Preview

Below are the financial statements of Ipsen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024
2023
Sales
3,400.6a
3,127.5a
Other revenues
173.9a
178.9a
Revenue
3,574.5a
3,306.4a
Cost of goods sold
-618.7a
-571.2a
Selling expenses
-957.2a
-917.1a
Research and development expenses
-686.6a
-619.3a
General and administrative expenses
-216.3a
-217.8a
Other operating income
120.6a
62.6a
Other operating expenses
-424.7a
-453.3a
Restructuring costs
-14.1a
-27.7a
Impairment losses
-280.9a
-253.4a
Operating income
496.7a
816a
Net financing costs
-8.6a
-19.4a
Other financial income and expenses
-56.4a
-35.1a
Income taxes
-74.9a
-136.2a
Share of net profit/(loss) from equity-accounted companies
0.5a
-5.4a
Net profit/(loss) from continuing operations
357.3a
619.9a
Net profit/(loss) from discontinued operations
-10a
27.3a
Consolidated net profit
347.3a
647.2a
Attributable to shareholders of Ipsen S.A.
345.9a
644.4a
Attributable to non-controlling interests
1.4a
2.8a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Ipsen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Ipsen's Universal Registration Document (URD) 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?